392 related articles for article (PubMed ID: 24464650)
1. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
2. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
3. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V
Gynecol Oncol; 2014 Aug; 134(2):338-45. PubMed ID: 24924122
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
5. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
6. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
7. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
8. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L
Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.
Yamamoto H; Oue N; Sato A; Hasegawa Y; Yamamoto H; Matsubara A; Yasui W; Kikuchi A
Oncogene; 2010 Apr; 29(14):2036-46. PubMed ID: 20101234
[TBL] [Abstract][Full Text] [Related]
10. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells.
Mehdawi LM; Prasad CP; Ehrnström R; Andersson T; Sjölander A
Mol Oncol; 2016 Nov; 10(9):1415-1429. PubMed ID: 27522468
[TBL] [Abstract][Full Text] [Related]
11. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
Wang B; Tang Z; Gong H; Zhu L; Liu X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
[TBL] [Abstract][Full Text] [Related]
14. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
15. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition.
Ren D; Minami Y; Nishita M
Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370
[TBL] [Abstract][Full Text] [Related]
16. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
17. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
[TBL] [Abstract][Full Text] [Related]
18. Amino acid limitation induces down-regulation of WNT5a at transcriptional level.
Wang Z; Chen H
Biochem Biophys Res Commun; 2009 Jan; 378(4):789-94. PubMed ID: 19063862
[TBL] [Abstract][Full Text] [Related]
19. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116.
Wang Z; Chen H
Anticancer Res; 2010 Nov; 30(11):4537-45. PubMed ID: 21115903
[TBL] [Abstract][Full Text] [Related]
20. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
